CHEK2 and Hereditary breast and ovarian cancer syndrome: In conclusion, we detected a significantly high prevalence of PALB2, BARD1, and BLM mutations, with a low frequency of mutant CHEK2 in the current Japanese cohort of 568 patients with BRCA1/2 WT HBOC syndrome.